NCNA

NuCana plc

0.33 USD
+0.00 (+0.52%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NuCana plc stock is up 10% since 30 days ago. The next earnings date is Apr 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 14.29% of the previous 6 February’s closed higher than January.

About NuCana plc

NuCana plc engages in the development of products for the treatment of cancer. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil.